Universe Pharmaceuticals INC Profit Margin

The latest profit margin for UPC is -2.3% as of March 2026. That compares with -48.64% in the prior-year period — up 95.3% year over year. That is below the Healthcare sector average of 13.45%. Investors often review this figure alongside Universe Pharmaceuticals INC's historical trend and sector peers before judging valuation or financial health.

Over the past year, UPC's profit margin moved from -48.64% to -2.3% — a 95.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Universe Pharmaceuticals INC's valuation or profitability profile.

Against Healthcare companies, UPC currently prints -2.3% for profit margin, while the sector average sits near 13.45%. That is roughly 117.1% below the sector mean. Large gaps often invite a closer look at Universe Pharmaceuticals INC's growth, margins, and balance sheet.

Profit Margin shows how effectively Universe Pharmaceuticals INC converts resources into returns. At -2.3%, UPC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -48.64% in the prior-year period — up 95.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting UPC's profit margin (-2.3%), review year-over-year change from -48.64%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.